GSK Manufacturing Consolidation Has Helped GMP Compliance, Firm Says
Executive Summary
GlaxoSmithKline's manufacturing streamlining has helped the company avoid trouble during the recent round of FDA good manufacturing practices enforcement, CEO J.P. Garnier told investors Oct. 23
You may also be interested in...
GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002
GlaxoSmithKline does not anticipate any immediate supply disruptions from an FDA investigation of its Cidra, Puerto Rico production facility
GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002
GlaxoSmithKline does not anticipate any immediate supply disruptions from an FDA investigation of its Cidra, Puerto Rico production facility
Paxil OS GMP Concerns Resolved By Year-End, GSK Says After Warning Letter
GlaxoSmithKline expects to resolve GMP issues related to production of Paxil oral suspension at its Certenejas Cidra, Puerto Rico facility by the end of the month, the company said